王绍洁,秦 凤

近年来，糖尿病发病率逐年升高，甲状腺功能异常是第二常见的内分泌疾病，多项研究显示，糖尿病患者常合并甲状腺功能异常，且当SCH与T2DM共存时，内分泌代谢紊乱可能进一步加剧骨质疏松症的发生。

糖尿病；甲状腺功能异常；亚临床甲状腺功能减退症；骨质疏松；骨密度；25羟维生素D

[1] Zhang C,Feng J,Wang S,et al.Incidence of and trends in hip fracture among adults in urban China:a nationwide retrospective cohort study[J].PLoS medicine,2020,17(8):e1003180. [2] Zheng X Q,Xu L,Huang J,et al.Incidence and cost of vertebral fracture in urban China:a 5-year population-based cohort study[J].International Journal of Surgery,2023,109(7):1910-1918. [3] Johnell O,Kanis J A.An estimate of the worldwide prevalence and disability associated with osteoporotic fractures[J].Osteoporosis international,2006,17:1726-1733. [4] Reid I R.A broader strategy for osteoporosis interventions[J].Nature Reviews Endocrinology,2020,16(6):333-339. [5] Wang Y,Meng X,Deng X,et al.Postprandial saturated fatty acids increase the risk of type 2 diabetes:a cohort study in a Chinese population[J].The Journal of Clinical Endocrinology&Metabolism,2018,103(4):1438-1446. [6] Knudsen N,Laurberg P,Rasmussen L B,et al.Small differences in thyroid function may be important for body mass index and the occurrence of obesity in the population[J].The Journal of Clinical Endocrinology&Metabolism,2005,90(7):4019-4024. [7] Elgazar E H,Esheba N E,Shalaby S A,et al.Thyroid dysfunction prevalence and relation to glycemic control in patients with type 2 diabetes mellitus[J].Diabetes&Metabolic Syndrome:Clinical Research&Reviews,2019,13(4):2513-2517. [8] Khatiwada S,Kc R,Sah S K,et al.Thyroid dysfunction and associated risk factors among Nepalese diabetes mellitus patients[J]. International journal of endocrinology,2015,2015(1):570198. [9] Han C,He X,**a X,et al.Subclinical hypothyroidism and type 2 diabetes:a systematic review and meta-analysis[J].PloS one,2015, 10(8):e0135233. [10] Kim H Y,Mohan S.Role and mechanisms of actions of thyroid hormone on the skeletal development[J].Bone research,2013,1(1):146-161. [11] Bassett J H D,Williams G R.Role of thyroid hormones in skeletal development and bone maintenance[J].Endocrine reviews,2016,37(2):135-187. [12] Lee W Y,Oh K W,Rhee E J,et al.Relationship between subclinical thyroid dysfunction and femoral neck bone mineral density in women[J].Archives of medical research,2006,37(4):511-516. [13] Magliano DJ,Boyko EJ.IDF diabetes atlas,in Idf diabetes atlas.Brussels:International Diabetes Federation;2021. [14] Hosomi K,Saito M,Park J,et al.Oral administration of Blautia wexlerae ameliorates obesity and type 2 diabetes via metabolic remodeling of the gut microbiota[J].Nature communications,2022,13(1):4477. [15] Rines A K,Sharabi K,Tavares C D J,et al.Targeting hepatic glucose metabolism in the treatment of type 2 diabetes[J].Nature reviews Drug discovery,2016,15(11):786-804. [16] Kurra S,Fink D A,Siris E S.Osteoporosis-associated fracture and diabetes[J].Endocrinology and Metabolism Clinics,2014,43(1):233-243. [17] Wang W,Jiang B,Ye S,et al.Risk factor analysis of bone mineral density based on feature selection in type 2 diabetes[C]//2018 IEEE International Conference on Big Knowledge(ICBK).IEEE,2018:221-226. [18] Nguyen K D,Bagheri B,Bagheri H.Drug-induced bone loss:a major safety concern in Europe[J].Expert opinion on drug safety, 2018,17(10):1005-1014. [19] **a S,Ma Z,Wang B,et al.A gene expression profile for the lower osteogenic potent of bone-derived MSCs from osteoporosis with T2DM and the potential mechanism[J].Journal of Orthopaedic Surgery and Research,2022,17(1):402. [20] Mao X,Li X,Hu W,et al.Retraction:Downregulated brain and muscle aryl hydrocarbon receptor nuclear translocator-like protein-1 inhibits osteogenesis of BMSCs through p53 in type 2 diabetes mellitus[J].Biology Open,2022,11(6):bio058581. [21] El-Tawdy A H F,Ibrahim E A H,AL SAKHAWY E,et al.Review on bone disease(osteoporosis)in diabetes mellitus[J].Journal of the Egyptian Society of Parasitology,2017,47(1):35-46. [22] Liu X,Chen F,Liu L,et al.Prevalence of osteoporosis in patients with diabetes mellitus:a systematic review and meta-analysis of observational studies[J].BMC Endocrine Disorders,2023,23(1):1. [23] Black DM,Rosen CJ,Clinical practice.postmenopausal osteoporosis.New England J Med.2016;374(3):254–62. [24] Biondi B,Cappola A R,Cooper D S.Subclinical hypothyroidism:a review[J].Jama,2019,322(2):153-160. [25] Vanderpump M P J,Tunbridge W M G.Epidemiology and prevention of clinical and subclinical hypothyroidism[J]. Thyroid, 2002,12(10):839-847. [26] El Hadidy E H M,Ghonaim M,El Gawad S S A,et al.Impact of severity,duration,and etiology of hyperthyroidism on bone turnover markers and bone mineral density in men[J].BMC Endocrine Disorders,2011,11:1-7. [27] Vestergaard P,Mosekilde L.Hyperthyroidism,bone mineral,and fracture risk—a meta-analysis[J].Thyroid,2003,13(6):585-593. [28] Pearce E N,Lazarus J H,Moreno-Reyes R,et al.Consequences of iodine deficiency and excess in pregnant women:an overview of current knowns and unknowns[J].The American journal of clinical nutrition,2016,104:918S-923S. [29] Stall G M,Harris S,Sokoll L J,et al.Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine[J].Annals of internal medicine,1990,113(4):265-269. [30] Sendak R A,Sampath T K,McPherson J M.Newly reported roles of thyroid-stimulating hormone and follicle-stimulating hormone in bone remodelling[J].International orthopaedics,2007,31:753-757. [31] Kim S M,Ryu V,Miyashita S,et al.Thyrotropin,hyperthyroidism,and bone mass[J].The Journal of Clinical Endocrinology&Metabolism, 2021,106(12):e4809-e4821. [32] Chubb S A P,Davis W A,Inman Z,et al.Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes:the Fremantle Diabetes Study[J].Clinical endocrinology,2005,62(4):480-486. [33] Kadiyala R,Peter R,Okosieme O E.Thyroid dysfunction in patients with diabetes:clinical implications and screening strategies[J]. International journal of clinical practice,2010,64(8):1130-1139. [34] 秦利平,乌丹,王斌莉,等.女性正常范围促甲状腺激素水平与骨代谢的相关性研究[J].中国骨质疏松杂志,2018,24(9):5. [35] 贾维娜,葛军,俞春芳,等.促甲状腺激素水平与老年2型糖尿病患者骨密度的相关性研究[J].中国骨质疏松杂志,2017,23(2):4. [36] 张利红,杨文娟,田竹芳,等.2型糖尿病患者促甲状腺激素与骨质疏松关系的研究[J].Chinese Journal of Osteoporosis,2019,25(1). [37] Saito M,Marumo K.Collagen cross-links as a determinant of bone quality:a possible explanation for bone fragility in aging, osteoporosis,and diabetes mellitus[J].Osteoporosis international,2010,21:195-214. [38] Abe E,Marians R C,Yu W,et al.TSH is a negative regulator of skeletal remodeling[J].Cell,2003,115(2):151-162. [39] Vitamin D.deficiency.Holick MF[J].N Engl J Med,2007,357:266-281. [40] Biondi B,Kahaly G J,Robertson R P.Thyroid dysfunction and diabetes mellitus:two closely associated disorders[J].Endocrine reviews,2019,40(3):789-824. [41] Pearce S H S,Brabant G,Duntas L H,et al.2013 ETA guideline:management of subclinical hypothyroidism[J].European thyroid journal,2013,2(4):215-228. [42] Sheu A,Greenfield J R,White C P,et al.Assessment and treatment of osteoporosis and fractures in type 2 diabetes[J].Trends in Endocrinology&Metabolism,2022,33(5):333-344. [43] Black D M,Rosen C J.Clinical practice.Postmenopausal osteoporosis N Engl J Med 374:254–262[EB/OL].(2016) [44] Weaver C M,Alexander D D,Boushey C J,et al.Calcium plus vitamin D supplementation and risk of fractures:an updated meta-analysis from the National Osteoporosis Foundation[J]. Osteoporosis International,2016,27:367-376. [45] Biondi B,Kahaly G J,Robertson R P.Thyroid dysfunction and diabetes mellitus:two closely associated disorders[J].Endocrine reviews,2019,40(3):789-824. [46] Sheu A,Greenfield J R,White C P,et al.Assessment and treatment of osteoporosis and fractures in type 2 diabetes[J].Trends in Endocrinology&Metabolism,2022,33(5):333-344.

点击下载PDF